Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium

被引:51
作者
Elbekai, Reem H. [1 ]
Ei-Kadi, Ayman O. S. [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Dent Pharm Ctr 3126, Edmonton, AB T6G 2N8, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
aryl hydrocarbon receptor; heavy metals; cytochrome p450; TCDD;
D O I
10.1016/j.toxlet.2007.05.009
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Heavy metals alter the carcinogenicity of AhR ligands by modulating the induction of the Cyp1a1 enzyme, but the mechanism(s) remain unresolved. In this study, the effect of the heavy metals, As3+, Cd2+, and Cr6+, on the transcriptional and posttranscriptional regulation of the Cyp1a1 gene was investigated in Hepa lclc7 cells. A time-dependent study showed that all metals significantly induced the basal Cyp1a1 mRNA, but only As3+ and Cd2+ further potentiated the inducible Cyp1a1 mRNA level. Alternately, Cr6+ inhibited the TCDD-mediated induction of Cyp1a1 mRNA. As3+ potentiated the induction of Cyp1a1 mRNA by TCDD only at 3 h and 6 h after treatment. Cd2+ on the other hand further potentiated the induction up to 24 h after treatment. The metal-mediated induction of Cyp1a1 mRNA was further potentiated by the protein synthesis inhibitor, cycloheximide and the 26S proteasome inhibitor, MG- 132, but completely inhibited by the RNA transcription inhibitor, actinomycin-D, implying a transcriptional regulation of the Cyp1a1 gene by the heavy metals. Not surprisingly, Cd2+ and Cr6+ activated the DNA-binding capacity of the AhR for the xenobiotic responsive element, as measured by the electrophoretic-mobility shift assay while all three metals induced AhR-dependent luciferase reporter gene expression in transiently transfected Hepa 1c1c7 cells. On the other hand, only As3+ increased the Cyp1a1 mRNA half-life while Cd2+ and Cr6+ increased the Cyp1a1 protein half-life, suggesting the involvement of posttranslational modifications. A significant decrease in TCDD-mediated induction of cyp1a1 activity was associated with an increase in HO-1 mRNA levels and a concomitant decrease in cellular heme content after all metal treatments. We clearly demonstrated that As3+, Cd2+, and Cr6+ increase Cyp1a1 mRNA levels at the transcriptional and posttranscriptional levels while decreasing Cyp1a1 activity at the posttranslational level. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:106 / 119
页数:14
相关论文
共 37 条
[1]   SODIUM ARSENITE INDUCED ALTERATIONS IN BILIRUBIN EXCRETION AND HEME METABOLISM [J].
ALBORES, A ;
CEBRIAN, ME ;
BACH, PH ;
CONNELLY, JC ;
HINTON, RH ;
BRIDGES, JW .
JOURNAL OF BIOCHEMICAL TOXICOLOGY, 1989, 4 (02) :73-78
[2]   A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species [J].
Aposhian, HV ;
Zakharyan, RA ;
Avram, MD ;
Sampayo-Reyes, A ;
Wollenberg, ML .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 198 (03) :327-335
[3]   Mechanisms of arsenite-mediated decreases in benzo[k] fluoranthene-induced human cytochrome P4501A1 levels in HepG2 cells [J].
Bessette, EE ;
Fasco, MJ ;
Pentecost, BT ;
Kaminsky, LS .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) :312-320
[4]   Nitric oxide and the regulation of gene expression [J].
Bogdan, C .
TRENDS IN CELL BIOLOGY, 2001, 11 (02) :66-75
[5]   Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export [J].
Davarinos, NA ;
Pollenz, RS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (40) :28708-28715
[6]   Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals [J].
Denison, MS ;
Nagy, SR .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 :309-334
[7]  
DENISON MS, 2002, CURRENT PROTOCOLS TO
[8]  
Elbekai R. H., 2005, FREE RADICAL BIO MED, V39, P1355
[9]   Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium [J].
Elbekai, RH ;
El-Kadi, AOS .
TOXICOLOGY, 2004, 202 (03) :249-269
[10]  
ELBEKAI RH, 2006, ASCORBIC ACID DIFFER